Cargando…
Recombinant human growth hormone in the treatment of Turner syndrome
Turner syndrome (TS) is a common chromosomal disorder in women that is associated with the absence of one of the X chromosomes. Severe short stature and a lack of pubertal development characterize TS girls, causing psychosocial problems and reduced bone mass. The growth impairment in TS seems to be...
Autor principal: | Spiliotis, Bessie E |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2643099/ https://www.ncbi.nlm.nih.gov/pubmed/19337425 |
Ejemplares similares
-
Metabolic consequences of recombinant human growth hormone therapy in patients with Turner syndrome
por: Gnacińska, Maria, et al.
Publicado: (2022) -
Height outcome of the recombinant human growth hormone treatment in Turner syndrome: a meta-analysis
por: Li, Ping, et al.
Publicado: (2018) -
Bone age is the best predictor of growth response to recombinant human growth hormone in Turner’s syndrome
por: Ismail, Nagwa Abdallah, et al.
Publicado: (2010) -
Hypertrophic scars in a patient with Turner's syndrome treated with recombinant growth hormone
por: Kędzia, Andrzej, et al.
Publicado: (2014) -
The role of p21/CIP1/WAF1 (p21) in the negative regulation of the growth hormone/growth hormone receptor and epidermal growth factor/epidermal growth factor receptor pathways, in growth hormone transduction defect
por: Kostopoulou, Eirini, et al.
Publicado: (2018)